Work

Phase 1 study of GCC2005, an allogeneic CD5-directed CAR-NK therapy, for patients with Relapsed/Refractory NK/T-cell malignancies

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-1043

Authors: Won-Seog Kim, Dok Hyun Yoon, Youngil Koh, Seok Jin Kim, Sang Eun Yoon, Hyungwoo Cho, Jaewon Hyung, Ja Min Byun, Hyesung Jeon, Seungryel Han

Institutions: Samsung Medical Center, Sungkyunkwan University, Asan Medical Center, University of Ulsan, Seoul National University Hospital

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417004987

Cites:

Cited by: 1

Related to: